Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    IRLAB Therapeutics

    MCap

    SEK653m

    Last close

    SEK14.10

    ▲ 1.50 (11.90%)

    VolitionRx

    MCap

    USD51m

    Last close

    USD0.60

    ▲ 0.05 (9.82%)

    Portobello SpA

    MCap

    EUR12m

    Last close

    EUR2.38

    ▲ 0.20 (9.17%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Midatech Pharma: Edison Open House Healthcare 2022

Midatech Pharma: Edison Open House Healthcare 2022

Biodexa Pharmaceuticals — 2 videos in collection

More on this equity

Midatech Pharma: is a drug-delivery specialist focused on re-engineering therapeutics through its technology platforms (MidaSolve – local drug-delivery, Qsphera – sustained-release, MidaCore – targeted delivery) to improve their bioavailability and delivery.

• Tell us about your drug delivery technology and why it’s necessary?
• How are your three different technology platforms: Q-Sphera, MidaSolve and MidaCore different from other drug delivery solutions?
• What advantages does Midatech offer over others in this space?
• What is the pipeline for Q-Sphera?
• How can your technology be used to enhance existing medicines?
• What can you tell us about your other key programme, MTX110?
• What are your commercialisation plans for MTX110?
• Which milestones should investors focus on in the coming year?
• How do you see the opportunities for partnerships and licensing opportunities developing?
• What does your cash runway look like?

< Previous
Next >

You may also be interested in these:

Healthcare

Midatech Pharma - Edison Open House interview

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free